|Table of Contents|

Application value of mixed reality technology in surgical treatment of retroperitoneal schwannoma

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 06
Page:
1039-1043
Research Field:
Publishing date:

Info

Title:
Application value of mixed reality technology in surgical treatment of retroperitoneal schwannoma
Author(s):
LI Shizhe1; 2; LIU Jinxin1; ZHANG He1; CHEN Ting1; LI Jiatong1; SHANG Guanning1
1.Department of Orthopedics,Shengjing Hospital Affiliated to China Medical University,Liaoning Shenyang 110022,China;2.Graduate School,Jinzhou Medical University,Liaoning Jinzhou 121001,China.
Keywords:
retroperitoneal schwannoma; mixed reality; preoperative evaluation; surgical approach; precision surgery
PACS:
R730.264
DOI:
10.3969/j.issn.1672-4992.2023.06.010
Abstract:
Objective：To investigate the clinical efficacy and application value of mixed reality technology in the surgical treatment of retroperitoneal schwannoma.Methods:The 19 patients with retroperitoneal schwannoma who were admitted to our hospital from January 2021 to April 2022 were retrospectively analyzed,including 5 males and 14 females.Age was (42.4±13.2)(20~72)years old.The largest tumor diameter was (6.65±2.82)(3.1~11.7)cm.All patients receieved enhanced three-dimensional reconstruction CT scan before operation.The size of the tumor and the surrounding anatomical relationship were analyzed by mixed reality technology,and the intraoperative blood loss and operation time were recorded.Meanwhile,all patients were followed up regularly.Results:All 19 patients underwent extraperitoneal approach.Among them,5 patients underwent rectus abdominis lateral incision approach,8 patients underwent ilioinguinal approach,5 patients underwent transsacral approach,and 1 patient underwent combined abdominal and sacral approach.All patients obtained complete tumor resection according to the preoperative protocol,and the blood vessels and nerves around the tumor were well preserved.The operation time was (86.3±39.8)(30~182)min,and the intraoperative blood loss was (266.8±413.9)(30~1 500)mL.Postoperative complications occurred in 3 patients,including lower extremity pain and abnormal urination.All cases were followed up for (8.0±3.7)（3～14）months.No tumor recurrence was found during the follow-up period.Conclusion:Surgical resection is the first choice for the treatment of retroperitoneal schwannoma,and an appropriate surgical approach should be taken in consideration before operation.Mixed reality technology can be used in the diagnosis and treatment of retroperitoneal schwannoma,which is helpful for precise operation.

References:

［1］GAO C,ZHU FC,MA BZ,et al.A rare case of giant retroperitoneal neurilemmoma ［J］.J Int Med Res,2020,48(9):300060520935302.
［2］Transatlantic Australasian Retroperitoneal Sarcoma Working G.Intercontinental collaborative experience with abdominal,retroperitoneal and pelvic schwannomas ［J］.Br J Surg,2020,107(4):452-463.
［3］IMPROTA L,TZANIS D,BOUHADIBA T,et al.Overview of primary adult retroperitoneal tumours ［J］.Eur J Surg Oncol,2020,46(9):1573-1579.
［4］REIS G,YILMAZ M,RAMBACH J,et al.Mixed reality applications in urology:Requirements and future potential ［J］.Ann Med Surg (Lond),2021,66:102394.
［5］SADEGHI AH,MATHARI SE,ABJIGITOVA D,et al.Current and future applications of virtual,augmented,and mixed reality in cardiothoracic surgery ［J］.Ann Thorac Surg,2022,113(2):681-691.
［6］ZHANG C,GAO H,LIU Z,et al.The potential value of mixed reality in neurosurgery ［J］.J Craniofac Surg,2021,32(3):940-943.
［7］CHYTAS D,NIKOLAOU VS.Mixed reality for visualization of orthopedic surgical anatomy ［J］.World J Orthop,2021,12(10):727-731.
［8］ALVENTOSA MATEU C,CASTILLO LOPEZ GA,ALBERT ANTEQUERA C.Retroperitoneal schwannoma ［J］.Rev Esp Enferm Dig,2018,110(9):597.
［9］MANDUARU R,MIRZA H.Ancient retroperitoneal schwannoma:A case report ［J］.Urol Case Rep,2022,40:101930.
［10］SULTAN S,BARRETT N,CURRAN S,et al.Non-functioning retroperitoneal abdominal schwannoma ［J］.BMJ Case Rep,2020,13(6):e233371.
［11］WU Q,LIU B,LU J,et al.Clinical characteristics and treatment strategy of retroperitoneal schwannoma adjacent to important abdominal vessels:three case reports and literature review ［J］.Front Surg,2020,7:605867.
［12］LAMRIS MA,EL YAMINE O,EL JAY SR,et al.Retroperitoneal shwannoma:A case report ［J］.Ann Med Surg (Lond),2021,70:102785.
［13］辛诚,王志彬,郑阔,等.骶前肿瘤手术治疗情况及临床特点分析 ［J］.结直肠肛门外科,2020,26(02):143-147,153. XIN C,WANG ZB,ZHENG K,et al.Surgical treatment and clinical characteristics of presacral tumors ［J］.Journal of Colorectal & Anal Surgery,2020,26(02):143-147,153.
［14］唐茂盛,苗成利,陈小兵,等.盆腔腹膜后肿瘤手术治疗的临床分析 ［J］.中华普通外科杂志,2021,36(09):668-671. TANG MS,MIAO CL,CHEN XB,et al.Experiences in surgical treatment of pelvic retroperitoneal neoplasms ［J］.Chinese Journal of General Surgery,2021,36(09):668-671.
［15］LUNGU AJ,SWINKELS W,CLAESEN L,et al.A review on the applications of virtual reality,augmented reality and mixed reality in surgical simulation:an extension to different kinds of surgery ［J］.Expert Rev Med Devices,2021,18(1):47-62.
［16］TEATINI A,KUMAR RP,ELLE OJ,et al.Mixed reality as a novel tool for diagnostic and surgical navigation in orthopaedics ［J］.Int J Comput Assist Radiol Surg,2021,16(3):407-414.
［17］KYAW BM,POSADZKI P,PADDOCK S,et al.Effectiveness of digital education on communication skills among medical students:systematic review and Meta-analysis by the digital health education collaboration ［J］.J Med Internet Res,2019,21(8):e12967.
［18］LI G,DONG J,WANG J,et al.The clinical application value of mixed-reality-assisted surgical navigation for laparoscopic nephrectomy ［J］.Cancer Med,2020,9(15):5480-5489.
［19］ZHOU H,ZHOU Z,LIANG J,et al.Clinical analysis of 53 cases of retroperitoneal schwannoma［J］.Chin J Cancer，2014,36(11):867-870.
［20］CARBONE F,PIZZOLORUSSO A,DI LORENZO G,et al.Multidisciplinary management of retroperitoneal sarcoma:diagnosis,prognostic factors and treatment ［J］.Cancers(Basel),2021,13(16):4016.
［21］GIANNONE F,FELLI E,CHERKAOUI Z,et al.Augmented reality and image-guided robotic liver surgery ［J］.Cancers(Basel),2021,13(24):6268.

Memo

Memo:
中国医科大学附属盛京医院345人才工程项目（编号：M0744，M0944）;中国博士后科学基金（编号：2021M693912）
Last Update: 1900-01-01